This research is part of the Horizon 2020 project: Interaction of squalene-based anti-cancer and neuroprotective drugs with cell membranes: in silico study

The so-called squalenoylation technology is based on fusing hydrophobic squalenic acid with the molecules of water-soluble drugs. Resulting conjugated molecules spontaneously self-assemble into nanoparticles, which deliver the drugs into the target cells efficiently

Print   Email